Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$80,128,453
in 11 filings, $80.1M under 10b5-1 plans

Net −$80,128,453. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dube Eric M −$38.5M CHIEF EXECUTIVE OFFICER sold 60% of stake
  2. Heerma Peter −$17.9M EVP, CHIEF COMMERCIAL OFFICER sold 71% of stake
  3. ROTE WILLIAM E. −$13.1M Chief Research Officer sold 68% of stake
  4. Cline Christopher R. −$3.2M CHIEF FINANCIAL OFFICER sold 37% of stake
  5. Inrig Jula −$2.8M EVP, Head of R&D & CMO sold 31% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-08-17 Heerma Peter Chief Commercial Officer Sale −1,407 $17.12 $24K 63,515
2021-08-17 Dube Eric M Chief Executive Officer Sale −7,836 $17.12 $134K 156,915
2021-08-17 Rosenberg Noah L. Chief Medical Officer Sale −1,407 $17.12 $24K 47,614
2021-08-17 ROTE WILLIAM E. Senior Vice President, R&D Sale −1,407 $17.12 $24K 35,731
2021-08-17 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −1,407 $17.12 $24K 37,548
2021-08-17 Clague Laura Chief Financial Officer Sale −1,407 $17.12 $24K 31,316
2021-08-13 Heerma Peter Chief Commercial Officer Grant or award +4,500 64,922
2021-08-13 Dube Eric M Chief Executive Officer Grant or award +17,500 164,751
2021-08-13 Rosenberg Noah L. Chief Medical Officer Grant or award +4,500 49,021
2021-08-13 ROTE WILLIAM E. Senior Vice President, R&D Grant or award +4,500 37,138
2021-08-13 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award +4,500 38,955
2021-08-13 Clague Laura Chief Financial Officer Grant or award +4,500 32,723
2021-07-28 Rosenberg Noah L. Chief Medical Officer Sale −1,250 $13.81 $17K 44,521
2021-07-16 ASELAGE STEVE Director Gift −3,000 161,794
2021-07-16 ASELAGE STEVE Director Gift +3,000 28,000
2021-06-02 Dube Eric M Chief Executive Officer Sale −4,780 $14.35 $69K 147,251
2021-06-01 Dube Eric M Chief Executive Officer Sale −4,782 $14.89 $71K 152,031
2021-05-14 COUGHLIN TIMOTHY Director Grant or award +3,000 35,000
2021-05-14 COUGHLIN TIMOTHY Director Grant or award · Stock option (right to buy) +9,000 9,000
2021-05-14 Bruhn Suzanne Louise Director Grant or award +3,000 8,250

Page 34 of 51 · 1,020 trades